• Dynamic, Collaborative and Supportive Work Environment
• Progressive and Far-Reaching Career Opportunities - Exciting Expansion into New Zealand (Brand New State of the Art Facility)
• Full Training is Provided on the Job and Development Support is Ongoing
• Permanent Full-Time Position- Auckland, NZ Location
• Monday to Friday – 6.30am to 3pm or 9.30am to 6pm Shifts Available – Free On-Site Parking
• The Payrate for Entry Level Starters is $24.50 Per Hour

Everybody knows someone who has spent time in hospital. During a time of upheaval and uncertainty, hospital patients deserve to experience and receive exceptional healthcare. Critical to this care is to offer the best quality personalised pharmaceutical products in a timely manner, and this is where our Production Technicians can make a difference.

About Slade Health:
Slade Health, a division of ICON Group, is one of Australia’s largest providers of sterile compounding services, including chemotherapy, analgesics, antibiotics and TPN products.
Slade Health supplies over one million infusions per annum to in-excess of 200 hospital partners via its three compounding facilities. It is now poised for its next phase of growth, creating exciting new opportunities within the organisation in New Zealand.

Slade Health New Zealand:
Slade Health is partnering with the Auckland District Health Board (ADHB) to build a new world-class Medsafe licenced compounding facility capable of producing chemotherapy, antibiotics, analgesics, and nutritional products.
The partnership with ADHB will see Slade Health supply compounded products for public hospitals in the Auckland region, which represents approximately 40% of New Zealand’s cancer patients.

About the role:
This is a permanent full time position, shifts available across the hours of 6.30 am to 6 pm, Monday – Friday. You will be provided with extensive training and will be responsible for:

• Decontamination of materials
• Printing labels and batch documents
• Compounding/mixing product in the cleanroom
• Checking, packing and labelling final product
• Ensuring completion of documentation

This role will also have the unique opportunity to be involved in the start-up phase of the site and will play an integral part in validation and certification activities in preparation for commencement of site operation. The Site will officially open in August, subject to the regulatory approvals.